Compare ESTA & AHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ESTA | AHG |
|---|---|---|
| Founded | 2004 | 2013 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.8B |
| IPO Year | 2018 | 2017 |
| Metric | ESTA | AHG |
|---|---|---|
| Price | $81.45 | $1.34 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $86.86 | N/A |
| AVG Volume (30 Days) | ★ 418.0K | 9.4K |
| Earning Date | 05-06-2026 | 08-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 42.67 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $61,208,000.00 | N/A |
| Revenue This Year | $28.05 | N/A |
| Revenue Next Year | $26.21 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 76.49 | N/A |
| 52 Week Low | $33.35 | $1.08 |
| 52 Week High | $85.56 | $2.50 |
| Indicator | ESTA | AHG |
|---|---|---|
| Relative Strength Index (RSI) | 64.31 | 28.70 |
| Support Level | $63.71 | $1.28 |
| Resistance Level | $83.31 | $1.67 |
| Average True Range (ATR) | 4.78 | 0.12 |
| MACD | 1.12 | 0.00 |
| Stochastic Oscillator | 79.29 | 22.99 |
Establishment Labs Holdings Inc is a medical technology company engaged in offering medical devices and aesthetic products. It is involved in the designing, manufacturing, and marketing of silicone-filled breast and body-shaping implants. The company markets its products under Motiva implants Brand. It distributes its products to medical distributors; and physicians, hospitals, and clinics in the form of direct sales. Its geographical segments are Europe, Latin America, Asia-Pacific/Middle East, and Others.
Akso Health Group is a social e-commerce platform based in China. The company collaborates with domestic e-commerce platforms and offers users a wide selection of high-quality and affordable products on its social e-commerce platform. It generates majority of the revenues from sale of medical devices business.